Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AALTO LDH ISOENZYME CONTROL SERUM

K-Number: K820360 · 1982-03-04

ApplicantAalto Scientific, Ltd.
Decision Date1982-03-04
Product CodeJJT
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

AALTO LDH ISOENZYME CONTROL SERUM is the device name listed in this FDA 510(k) record. The listed applicant is Aalto Scientific, Ltd.. It received FDA 510(k) clearance on 1982-03-04 under 510(k) number K820360. The device is classified under product code JJT. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AALTO LDH ISOENZYME CONTROL SERUM?

AALTO LDH ISOENZYME CONTROL SERUM is a medical device that received FDA 510(k) clearance on 1982-03-04. The listed applicant is Aalto Scientific, Ltd.. The 510(k) number is K820360.

When did AALTO LDH ISOENZYME CONTROL SERUM receive FDA 510(k) clearance?

AALTO LDH ISOENZYME CONTROL SERUM received FDA 510(k) clearance on 1982-03-04, under 510(k) number K820360.

Who is the listed applicant for AALTO LDH ISOENZYME CONTROL SERUM?

The FDA 510(k) record lists Aalto Scientific, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AALTO LDH ISOENZYME CONTROL SERUM?

The FDA product code for AALTO LDH ISOENZYME CONTROL SERUM is JJT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Aalto Scientific, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K163629Audit MicroControls Linearity FD Tumor Markers IIK161874Audit MicroControls Linearity DROP LQ Blood GlucoseK130762AUDIT MICROCV THERAPEUTIC DRUG (TDM) LINEARITY SETK130764AUDIT MICROCV VITAMIN D LINEARITY SETK130157AUDIT MICROCV BETA-HYDROXYBUTYRIC ACID LINEARITY SETK112742AUDIT MICROLQ SPINAL FLUID CONTROL

View all 31 devices →

Related Devices (Code: JJT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K090940SPOTCHECK BLOOD SPOT CONTROL, ASSAYEDAstoria-Pacific, Inc.K062751MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKERQuantimetrix Corp.K030768CLINIQA LIQUID QC CARDIAC MARKER CONTROL LEVELS 1, 2 & 3, TRI-LEVELCliniqa CorporationK030102ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3Bayer Healthcare, LLCK021498LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1, 2, 3, AND TRILEVELBio-RadK012656LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1,2,3, MODELS 646,647,648Bio-Rad

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑